Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1988-8-17
|
pubmed:abstractText |
The response to three quinolones of a clinical isolate of Streptococcus faecalis was studied by continuous turbidimetric monitoring, by viable counting, and in an in-vitro model of the treatment of bacterial cystitis. Dense populations (c. 8 x 10(6) cfu/ml) responded to ciprofloxacin, norfloxacin and enoxacin at concentrations below the conventionally determined MIC, but variants, shown to exhibit decreased susceptibility, emerged during overnight incubation. The variants were cross-resistant to each of the three quinolones, but the resistance was lost on subculture in drug-free broth. At a concentration of ten-fold MIC, ciprofloxacin was more bactericidal than norfloxacin or enoxacin. In experiments in the bladder model, doses of ciprofloxacin achieving a peak concentration of 10, 50 or 250 mg/l suppressed bacterial growth for 20 h or more. The doses of norfloxacin or enoxacin required to achieve a comparable effect were higher than those of ciprofloxacin. A reduction in susceptibility, as judged by comparative disc testing, occurred after two cycles of exposure to norfloxacin or enoxacin in experiments in which the peak concentration achieved was 50 mg/l, but not when the peak was 250 mg/l. Reduced susceptibility to ciprofloxacin developed only in experiments in which a lower peak concentration of 10 mg/l was achieved.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Infective Agents, Urinary,
http://linkedlifedata.com/resource/pubmed/chemical/Ciprofloxacin,
http://linkedlifedata.com/resource/pubmed/chemical/Culture Media,
http://linkedlifedata.com/resource/pubmed/chemical/Enoxacin,
http://linkedlifedata.com/resource/pubmed/chemical/Naphthyridines,
http://linkedlifedata.com/resource/pubmed/chemical/Norfloxacin
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0305-7453
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
545-54
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3134318-Anti-Infective Agents, Urinary,
pubmed-meshheading:3134318-Ciprofloxacin,
pubmed-meshheading:3134318-Culture Media,
pubmed-meshheading:3134318-Drug Resistance, Microbial,
pubmed-meshheading:3134318-Enoxacin,
pubmed-meshheading:3134318-Enterococcus faecalis,
pubmed-meshheading:3134318-Humans,
pubmed-meshheading:3134318-Naphthyridines,
pubmed-meshheading:3134318-Nephelometry and Turbidimetry,
pubmed-meshheading:3134318-Norfloxacin,
pubmed-meshheading:3134318-Urinary Bladder
|
pubmed:year |
1988
|
pubmed:articleTitle |
The response of Streptococcus faecalis to ciprofloxacin, norfloxacin and enoxacin.
|
pubmed:affiliation |
Department of Microbiology, University Hospital, Queen's Medical Centre, Nottingham, UK.
|
pubmed:publicationType |
Journal Article
|